CNTL-sfGFP
(Plasmid
#240100)
-
PurposeSP6-GFP plasmid
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 240100 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 |
Backbone
-
Vector backbonepCS2+MCS-P2A-sfGFP
-
Backbone manufacturerJason Berman (Addgene Plasmid #74668)
- Backbone size w/o insert (bp) 4915
- Total vector size (bp) 4075
-
Modifications to backboneRemoved upstream sequences and added Kozak sequence to get GFP in frame
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namesfGFP
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2024.07.12.603270 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
CNTL-sfGFP was a gift from Genevieve Kendall (Addgene plasmid # 240100 ; http://n2t.net/addgene:240100 ; RRID:Addgene_240100) -
For your References section:
Rhabdomyosarcoma fusion oncoprotein initially pioneers a neural signature in vivo. Kucinski J, Tallan A, Taslim C, Vontell AM, Silvius KM, Wang M, Cannon MV, Stanton BZ, Kendall GC. Cell Rep. 2025 Jul 22;44(7):115923. doi: 10.1016/j.celrep.2025.115923. Epub 2025 Jul 3. 10.1016/j.celrep.2025.115923 PubMed 40614256